Dr. Schultz is a subject matter expert in radiochemistry, radiopharmaceutical science, environmental radiochemistry, and nuclear science. His research platform includes quantitative redox biology and free radical chemistry toward the development of a more detailed understanding of cancer and for the development of new targeted imaging and therapy agents for cancer.